High-Impact HIV Prevention and Surveillance Programs for Health Departments

High-Impact HIV Prevention and Surveillance Programs for Health Departments is sponsored by CDC National Center for HIV, Viral Hepatitis, STD, and TB Prevention. This opportunity supports mission-aligned projects and measurable outcomes.

Funding for High-Impact HIV Prevention and Surveillance Programs for Health Departments | CDC NCHHSTP Skip directly to site content Funding for High-Impact HIV Prevention and Surveillance Programs for Health Departments Notice of Funding Opportunity (NOFO) number: CDC-RFA-PS-24-0047 Application Due Date: April 29, 2024, 11:59 pm ET Letter of Intent Due Date: February 23, 2024 Contact: nofoinfo@cdc.

gov CDC announces the availability of fiscal year 2024 funds for a cooperative agreement for health departments to implement high-impact HIV prevention and surveillance programs. The purpose of this notice of funding opportunity (NOFO) is to implement a comprehensive HIV prevention and surveillance program to prevent new HIV infections and improve the health of people with HIV.

The NOFO aligns with CDC's Division of HIV Prevention (DHP) strategic focus areas to bolster: Syndemic and whole-person approaches to HIV prevention. Click on the "Search Grants" tab. Enter "CDC-RFA-PS-24-0047" into the "Basic Search Criteria-Opportunity Announcement.

Select "Archived" as the "Opportunity Status".

Funding tables and resource distribution Access the following document for anticipated funding ranges for budget period 1 and subsequent budget periods: Funding Tables for Core HIV Prevention and Surveillance and Ending the HIV Epidemic (EHE) The following document contains a list of counties for funding distribution: Counties per state representing 30% or greater HIV diagnosis in 2021 The funding opportunity is for eligible health departments for core prevention and surveillance funding.

There are approximately 32 additional awards for eligible health departments that represent the 57 jurisdictions included in the U.S. Ending the HIV Epidemic initiative. These jurisdictions include: District of Columbia (DC). Read the following document to learn about each recipient's total funding: Recipient Funding Amounts Year 1 (2024) CDC strongly urges you to complete a letter of intent (LOI) prior to submitting your application.

The purpose of this letter is to inform CDC of your interest in applying for funding under PS24-0047. Although a LOI is not required and non-binding, it is highly recommended. A LOI allows CDC program staff to estimate the number of and plan for the review of submitted applications.

A completed LOI must be electronically submitted to nofoinfo@cdc. gov . An email acknowledging CDC's receipt of a LOI submission will be sent to the potential applicant.

The application must include complete, stand-alone sections (e.g. project abstract, narrative, budget and budget justification). Each section represent a requested funding program (core and demonstration project). This ensures that each request for a funding program is easily identified and provided to the respective review panel.

Each detailed budget and narrative justification should support the activities for the first year of funding. Additionally, it should support a summary narrative for the entire project period. Application review information Applications will be reviewed for completeness.

Incomplete applications and applications that are non-responsive to the eligibility criteria will not advance through the review process. Applicants will be notified if the application did not meet submission requirements. All eligible and technically acceptable applications will be funded for the core HIV program.

For demonstration projects, all applications deemed eligible and technically acceptable by the review panel will be funded in order of: Relevance to DHP program priorities. Successful applicants will receive a Notice of Award (NoA) from the CDC Office of Grants Services (OGS). The NoA shall be the only binding, authorizing document between the recipient and CDC.

The NoA will be: Signed by an authorized Grants Management Officer Emailed to the principle investigator (PI) Mailed (as a hard copy) to the recipient fiscal officer identified in the application Any application awarded in response to this NOFO will be subject to the following requirements: Frequently asked questions Read the following Frequently Asked Questions (FAQ) document with questions received from potential applicants: PS-24-0047 Frequently Asked Questions Programmatic technical assistance Erica K.

Dunbar, Senior Advisor for Program Department of Health and Human Services Centers for Disease Control and Prevention Financial, awards management, and budget assistance Edna Green, Grants Management Specialist Department of Health and Human Services Office of Grants Services For assistance with submission difficulties related to Grants. gov , contact the Contact Center by phone at 1-800-518-4726.

Hours of operation are 24 hours a day, 7 days a week, except on federal holidays. All other submission questions Technical Information Management Section Department of Health and Human Services CDC Office of Financial Resources Office of Grants Services CDC Telecommunications for persons with hearing loss is available at: TTY 1-888-232-6348.

Attachments and information resources Below is the list of Program Guidance and/or related links referenced in the NOFO. Cluster detection and response HIV Cluster Detection and Response Guidance for Health Departments Principles of Community Engagement (Second Edition) (cdc.

gov) Content review guidelines Program Guidance on the Review of HIV-related Educational and Information Materials for CDC Assistance Programs, updated June 2016 Assurance of Compliance Form for the Program Guidance on the Review of HIV-related Educational and Information Materials for CDC Assistance Programs, updated June 2016 Data-to-Care Program Guidance Data security and confidentiality guidance Data Security and Confidentiality Guidelines for HIV, Viral Hepatitis, Sexually Transmitted Disease, and Tuberculosis Programs, 2011 Certification of compliance with the CDC Data Security and Confidentiality Guidelines and Designation of Overall Responsible Party (ORP) Assurance of Confidentiality Statement Epidemiologic profile guidance Integrated Guidance for Developing Epidemiologic Profiles – HIV Prevention and Ryan White HIV/AIDS Programs Planning, 2014 High-impact prevention (HIP) High Impact HIV Prevention HIV Planning Group (HPG) – Plans and processes HIV Planning Guidance, 2012 EHE Planning Guidance, 2019 HIV Surveillance Overview Revised Recommendations for HIV Testing of Adults, Adolescents, and Pregnant Women in Health-Care Settings, 2006 Implementing HIV Testing in Nonclinical Settings – A Guide for HIV Testing Providers, 2016 Laboratory testing guidance Laboratory testing for the diagnosis of HIV infection: updated recommendations, 2014 Recommendations for Partner Services Programs for HIV Infection, Syphilis, Gonorrhea, and Chlamydial Infection, 2008 Perinatal HIV prevention program guidance Perinatal Program Guidance CDC PrEP Ancillary Support Services Program Guidance for Health Departments (Revised December 2021) Preexposure Prophylaxis for the Prevention of HIV Infection in the United States – 2021 Clinical Practice Guideline Updated Guidelines for Antiretroviral Postexposure Prophylaxis After Sexual, Injection Drug Use, or Other Nonoccupational Exposure to HIV—United States, 2016 Prevention with Positives (PwP) guidelines Recommendations for HIV prevention with adults and adolescents with HIV in the United States, 2014 Social determinants of health (SDOH) HHS Call to Action: Addressing Health-Related Social Needs in Communities Across the Nation (hhs.

gov) – Call to Action: Addressing Health-Related Social Needs in Communities Across the Nation (hhs. gov) Syringe services programs (SSP) HHS SSP Implementation Guidance 2016 (cdc.

gov) CDC Program Guidance for Implementing Certain Components of Syringe Services Programs, 2016 SSP Technical Package (Syringe Services Programs (SSPs) | CDC) National Center for HIV, Viral Hepatitis, STD, and Tuberculosis Prevention CDC's National Center for HIV, Viral Hepatitis, STD, and Tuberculosis Prevention is committed to a future free of HIV, Viral Hepatitis, STDs, and Tuberculosis.

A Day in the Life at NCHHSTP National Center for HIV, Viral Hepatitis, STD, and Tuberculosis Prevention (NCHHSTP) Leaders Letters from the Director Tuberculosis Advisory Council